• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒涂层对溶瘤腺病毒-磁性纳米颗粒复合物活性的影响。

Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes.

机构信息

Department of Pharmacy, Mahidol University, Bangkok 10400, Thailand.

出版信息

Biomaterials. 2012 Jan;33(1):256-69. doi: 10.1016/j.biomaterials.2011.09.028. Epub 2011 Oct 5.

DOI:10.1016/j.biomaterials.2011.09.028
PMID:21978891
Abstract

Limitations to adenovirus infectivity can be overcome by association with magnetic nanoparticles and enforced infection by magnetic field influence. Here we examined three core-shell-type iron oxide magnetic nanoparticles differing in their surface coatings, particle sizes and magnetic properties for their ability to enhance the oncolytic potency of adenovirus Ad520 and to stabilize it against the inhibitory effects of serum or a neutralizing antibody. It was found that the physicochemical properties of magnetic nanoparticles are critical determinants of the properties which govern the oncolytic productivities of their complexes with Ad520. Although high serum concentration during infection or a neutralizing antibody had strong inhibitory influence on the uptake or oncolytic productivity of the naked virus, one particle type was identified which conferred high protection against both inhibitory factors while enhancing the oncolytic productivity of the internalized virus. This particle type equipped with a silica coating and adsorbed polyethylenimine, displaying a high magnetic moment and high saturation magnetization, mediated a 50% reduction of tumor growth rate versus control upon intratumoral injection of its complex with Ad520 and magnetic field influence, whereas Ad520 alone was inefficient. The correlations between physical properties of the magnetic particles or virus complexes and oncolytic potency are described herein.

摘要

通过与磁性纳米粒子结合,并通过磁场影响强制感染,可以克服腺病毒感染力的限制。在这里,我们研究了三种核壳型氧化铁磁性纳米粒子,它们在表面涂层、粒径和磁性能方面存在差异,以研究它们增强溶瘤腺病毒 Ad520 效力并抵抗血清或中和抗体抑制作用的能力。结果发现,磁性纳米粒子的物理化学性质是决定其与 Ad520 复合物的性质的关键因素,这些性质决定了其溶瘤生产力。虽然在感染过程中高浓度的血清或中和抗体对裸病毒的摄取或溶瘤生产力有很强的抑制作用,但有一种粒子类型被确定可以同时抵抗这两种抑制因素,同时增强内化病毒的溶瘤生产力。这种带有二氧化硅涂层和吸附聚乙烯亚胺的粒子类型,具有高磁矩和高饱和磁化强度,在肿瘤内注射其与 Ad520 的复合物并施加磁场影响后,可使肿瘤生长速率相对于对照组降低 50%,而单独使用 Ad520 则无效。本文描述了磁性粒子或病毒复合物的物理性质与溶瘤效力之间的相关性。

相似文献

1
Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes.纳米颗粒涂层对溶瘤腺病毒-磁性纳米颗粒复合物活性的影响。
Biomaterials. 2012 Jan;33(1):256-69. doi: 10.1016/j.biomaterials.2011.09.028. Epub 2011 Oct 5.
2
Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force.利用磁性纳米颗粒和磁力增强溶瘤腺病毒效力。
Mol Pharm. 2010 Aug 2;7(4):1069-89. doi: 10.1021/mp100123t.
3
Using a magnetic field to redirect an oncolytic adenovirus complexed with iron oxide augments gene therapy efficacy.利用磁场重定向与氧化铁复合的溶瘤腺病毒可增强基因治疗的效果。
Biomaterials. 2015 Oct;65:163-74. doi: 10.1016/j.biomaterials.2015.07.001. Epub 2015 Jul 2.
4
A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.一种用于生成携带一个或两个转基因的溶瘤腺病毒载体的简化系统。
Cancer Gene Ther. 2008 Mar;15(3):173-82. doi: 10.1038/sj.cgt.7701105. Epub 2007 Dec 21.
5
Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.在转移性肿瘤模型中,瘤内联合给予透明质酸酶和溶瘤腺病毒可增强病毒效力。
Clin Cancer Res. 2008 Jun 15;14(12):3933-41. doi: 10.1158/1078-0432.CCR-07-4732.
6
Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.在具有复制能力的腺病毒背景下抗凋亡蛋白与肿瘤坏死因子的功能相互作用。
Gene Ther. 2005 Sep;12(17):1333-46. doi: 10.1038/sj.gt.3302555.
7
Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus.双肿瘤靶向 pH 敏感和生物可还原聚合物复合溶瘤腺病毒。
Biomaterials. 2015 Feb;41:53-68. doi: 10.1016/j.biomaterials.2014.11.021. Epub 2014 Dec 5.
8
A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.一种survivin介导的溶瘤腺病毒可诱导肺癌细胞发生非凋亡性细胞死亡,并在体内显示出抗肿瘤潜力。
J Gene Med. 2006 Oct;8(10):1232-42. doi: 10.1002/jgm.953.
9
Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.利用纤维扣环上展示随机肽的腺病毒文库进行胰腺癌的溶瘤病毒治疗。
Gene Ther. 2009 May;16(5):669-80. doi: 10.1038/gt.2009.1. Epub 2009 Feb 19.
10
Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.在头颈部癌临床前模型中,放疗或顺铂联合治疗可增强Ad5/35嵌合溶瘤腺病毒的效力。
Cancer Gene Ther. 2009 May;16(5):383-92. doi: 10.1038/cgt.2008.90. Epub 2008 Nov 14.

引用本文的文献

1
Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses.细胞外基质重新归一化以改善溶瘤病毒对冷肿瘤的渗透。
Front Immunol. 2025 Jan 8;15:1535647. doi: 10.3389/fimmu.2024.1535647. eCollection 2024.
2
Nanoengineering-armed oncolytic viruses drive antitumor response: progress and challenges.纳米工程武装的溶瘤病毒驱动抗肿瘤反应:进展与挑战
MedComm (2020). 2024 Oct 10;5(10):e755. doi: 10.1002/mco2.755. eCollection 2024 Oct.
3
Emerging delivery strategy for oncolytic virotherapy.溶瘤病毒疗法的新兴递送策略。
Mol Ther Oncol. 2024 Apr 29;32(2):200809. doi: 10.1016/j.omton.2024.200809. eCollection 2024 Jun 20.
4
Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer.头颈部癌溶瘤病毒疗法的临床进展与未来方向
Cancers (Basel). 2023 Nov 4;15(21):5291. doi: 10.3390/cancers15215291.
5
Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective.溶瘤病毒工程与应用:癌症免疫治疗视角
Viruses. 2023 Jul 28;15(8):1645. doi: 10.3390/v15081645.
6
Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review.溶瘤单纯疱疹病毒 IFNβ 治疗癌症的临床前疗效:系统评价。
Front Immunol. 2023 Mar 31;14:1085940. doi: 10.3389/fimmu.2023.1085940. eCollection 2023.
7
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.晚期溶瘤病毒疗法策略:当前技术创新与临床方法
Pharmaceutics. 2022 Aug 29;14(9):1811. doi: 10.3390/pharmaceutics14091811.
8
Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers.疫苗作为上皮癌T细胞疗法的启动工具
Cancers (Basel). 2021 Nov 19;13(22):5819. doi: 10.3390/cancers13225819.
9
Oncolytic virus therapy in cancer: A current review.癌症中的溶瘤病毒疗法:当前综述
World J Virol. 2021 Sep 25;10(5):229-255. doi: 10.5501/wjv.v10.i5.229.
10
Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer.高效递送和复制溶瘤病毒以成功治疗头颈部癌症。
Int J Mol Sci. 2020 Sep 25;21(19):7073. doi: 10.3390/ijms21197073.